comparemela.com
Latest Breaking News On - Fabrizio giordanetto - Page 1 : comparemela.com
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
/PRNewswire/ DP Technology, an "AI for Science" new paradigm-driven company, today announced the nomination of DPT0218, a novel small molecule targeting Kv1..
Beijing
China
Xiaomin-zhang
Anna-lena-unterweger
Fabrizio-giordanetto
Johnt-chang
Eli-lilly
Weijie-sun
Prnewswire-dp-technology
Company-lilly
Dp-technology
De-shaw-research
vimarsana © 2020. All Rights Reserved.